IP Library Granted Patent US 9,017,963
Granted Patent B2
US 9,017,963 · App. 10/502,882 · Granted Apr 28, 2015

Method for detecting microorganisms

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,017,963
App. No.
10/502,882
Granted
Apr 28, 2015
Kind
B2
Abstract

Described herein are methods of detecting a wound infection and for detecting the presence or absence of microorganisms, for example, wound pathogens in a sample, by contacting a sample with an enzyme produced and/or secreted by the bacteria, and detecting modification or the absence of modification of the substrate, as an indicator of the presence or absence of the enzyme in the sample. The present invention also features a biosensor for detecting the presence or absence of bacteria in a sample.

Claims (14)

1. A method for detecting the presence or absence of a wound pathogenic bacterium in a sample of wound fluid obtained from a subject, comprising the steps of:

(a) contacting the sample with a detectably labeled polypeptide substrate comprising the amino acid sequence of SEQ ID NO: 1, 2, 3, 4, 5, 9 or 10, or an amino acid sequence having at least 99% sequence identity to SEQ ID NO: 1, 2, 3, 4, 5, 9 or 10; and

(b) detecting the modification or the absence of the modification of said substrate wherein the presence of said modification of said substrate indicates the presence of said wound-pathogenic bacterium in said sample, and the absence of modification of said substrate indicates the absence of said wound-pathogenic bacterium in said sample.

2. The method of claim 1 , wherein said substrate is on a solid support.

3. The method of claim 2 , wherein said solid support comprises a material required to be free of microbial contaminants.

4. The method of claim 2 , wherein said solid support is selected from the group consisting of a wound dressing, a container for holding body fluids, a disk, a scope, a filter, a lens, foam, cloth, paper, a suture, and a swab.

5. The method of claim 4 , wherein said container for holding body fluids is selected from the group consisting of a urine collection bag, a blood collection bag, a plasma collection bag, a test tube, a catheter, and a well of a microplate.

6. A method for detecting the presence or absence of Staphylococcus aureus in a sample of wound fluid obtained from a subject, comprising the steps of:

(a) contacting the sample with a detectably labeled polypeptide substrate comprising the amino acid sequence of SEQ ID NO: 1 or having at least 95% sequence identity to SEQ ID NO: 1, the substrate being for a protease produced and/or secreted by said Staphylococcus aureus but not produced and/or secreted by a non-wound-pathogenic bacterium or the subject, under conditions that result in modification of said substrate by said protease; and

(b) detecting the modification or the absence of the modification of said substrate, wherein modification of said substrate indicates the presence of Staphylococcus aureus in said sample, and wherein the absence of modification of said substrate indicates the absence of Staphylococcus aureus in said sample.

7. The method of claim 6 , wherein said substrate is on a solid support.

8. The method of claim 7 , wherein said solid support comprises a material required to be free of microbial contaminants.

9. The method of claim 7 , wherein said solid support is selected from the group consisting of a wound dressing, a container for holding body fluids, a disk, a scope, a filter, a lens, foam, cloth, paper, a suture, and a swab.

10. The method of claim 9 , wherein said container for holding body fluids is selected from the group consisting of a urine collection bag, a blood collection bag, a plasma collection bag, a test tube, a catheter, and a well of a microplate.

Assignments (9)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TO CORRECT NAME OF RECEIVING PARTY PREVIOUSLY RECORDED ON REEL 033698 FRAME 0810. ASSIGNOR(S) HEREBY CONFIRMS THE WOUNDCHEK LABORATORIES (US), INC. Recorded Sep 18, 2014
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: WOUNDCHEK LABORATORIES (US), INC.
Reel/Frame 033774/0743 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2014
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: WOUNDCHECK LABORATORIES (US), INC.
Reel/Frame 033698/0810 →
CONTRIBUTION AND ASSUMPTION AGREEMENT Recorded Jul 22, 2014
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: WOUNDCHEK LABORATORIES (US), INC.
Reel/Frame 033379/0634 →
SECURITY AGREEMENT Recorded Oct 29, 2013
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 031508/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 19, 2012
From: SYSTAGENIX WOUND MANAGEMENT, LIMITED
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 028584/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2012
From: ECI BIOTECH INC.
To: SYSTAGENIX WOUND MANAGEMENT, LIMITED
Reel/Frame 027534/0047 →
CHANGE OF NAME Recorded May 15, 2007
From: EXPRESSIVE CONSTRUCTS INC.
To: ECI BIOTECH INC.
Reel/Frame 019287/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2005
From: SANDERS, MITCHELL C.; LOWE, ADRIAN M.; HAMILTON, MAUREEN A.; COLPAS, GERARD J.
To: EXPRESSIVE CONSTRUCTS, INC.
Reel/Frame 015773/0100 →